The U.S. Food and Drug Administration has approved an updated label for Unloxcyt (cosibelimab-ipdl) for the treatment of ...
The drugs have soared in popularity, with some men taking them for unapproved uses like anti-aging or increasing muscle mass.
Promo materials should also refrain from positioning one approved biosimilar as better than another for the same reference ...
The U.S. Food and Drug Administration has approved an expanded indication for Eli Lilly's Jaypirca (pirtobrutinib), the first and only noncovalent Bruton tyrosine kinase (BTK) inhibitor for adults ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The FDA has restricted the type ...
The U.S. Food and Drug Administration (FDA) recently announced a recall of Boar’s Head Grated Pecorino Romano Cheese and FS Grated Romano Cheese after discovering that they may be contaminated with ...
The FDA announced six more awardees for the FDA Commissioner's National Priority Voucher (CNPV) pilot program designed to accelerate approval of drugs that address unmet needs or whose makers have ...
Wellbeing Whisper on MSN
FDA recall of blood pressure drug: What patients must know
More than 11,000 bottles of a widely prescribed blood pressure medication have been pulled from pharmacy shelves nationwide ...
Some four years into Jemperli’s commercial life span, a rift has emerged between GSK subsidiary Tesaro and the potential cancer blockbuster’s original developer, AnaptysBio. Tesaro has filed a lawsuit ...
Alert FDA Approves Third-Ever Drug for Lupus Nephritis Obinutuzumab (Gazyva) is the first drug to be approved for lupus nephritis since the approvals of belimumab (Benlysta) in 2020 and voclosporin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback